Cart
sales@molnova.com
trans-12-Cyclohexanediol
CAS No. 1460-57-7
trans-12-Cyclohexanediol ( —— )
Catalog No. M19563 CAS No. 1460-57-7
14-cyclohexanediol and 12-hexanediol have a synergistic retardation effect on percutaneous absorption and penetration of metronidazole (MTZ).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | 37 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Nametrans-12-Cyclohexanediol
-
NoteResearch use only not for human use.
-
Brief Description14-cyclohexanediol and 12-hexanediol have a synergistic retardation effect on percutaneous absorption and penetration of metronidazole (MTZ).
-
Description14-cyclohexanediol and 12-hexanediol have a synergistic retardation effect on percutaneous absorption and penetration of metronidazole (MTZ).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1460-57-7
-
Formula Weight116.16
-
Molecular FormulaC6H12O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESO[C@@H]1CCCC[C@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Zhang Y et al. Effect of hydroxyl groups and rigid structure in 14-cyclohexanediol on percutaneous absorption of metronidazole. AAPS PharmSciTech. 2014 Aug;15(4):973-80.
molnova catalog
related products
-
Neuropeptide W-23(hu...
Neuropeptide W-23(human) is an endogenous ligand for NPBW1 and NPBW2. NPW-23 increases the ICa,L in transfected human embryonic kidney 293 cells and VSMCs via GPR7. NPW-23 increases the expression of pan phospho-PKC, intracellular diacylglycerol level, and the second messenger catalyzed by PLC.
-
Neohesperidose
Neohesperidose is a natural product isolated from species of?typha.
-
Dolasetron Mesylate
Dolasetron Mesylate is an antagonist of the 5-HT3 receptor and can be used in research on the treatment of vomiting and nausea following chemotherapy.
